an RNA vaccine that protects against coxsackievirus B3 challenge, allowing production of the viral polyprotein; appeared safe in vivo, causing no detectable pathology following injection & conferred substantial protection against virus challenge, either with an attenuated recombinant CVB3, or with the highly pathogenic wt virus